Comment by
N0taP00p on May 03, 2023 5:33pm
I would hope they provide two sets of data one with the 12 included one without. Letter of the law versus spirit of the law, considering there are bladders at stake. I would also hope they hit the submit button by the time Q1 results are announced in May.
Comment by
wildbird1 on May 03, 2023 6:23pm
Eoganacht..."patients who remain" could simply refer to the fact that some patients have been removed from study11, as stipulated in the 2Q2020 Newsletter, were TLT said 4/12 undertreated patients were removed from study11.
Comment by
enriquesuave on May 03, 2023 7:08pm
Yes Eoganacht. I would think that even NR patients with progression would be counted as evaluable, and as NR. It clearly states 8 out of 12 evaluable patients are CR, 2 IR and 2 NR. With more clarification this will be made clear.
Comment by
Eoganacht on May 03, 2023 8:19pm
I very much hope yours is the correct interpretation Enrique. If it is we could be looking at that 50% - 60% complete durable response.
Comment by
Eoganacht on May 04, 2023 2:22pm
Just one more senior moment. I meant to write - 40% - 50% complete durable response.